(Q37426672)

20 August 2017

1 reference

title

Effects on coronary atherosclerosis by targeting low-density lipoprotein cholesterol with statins (English)

1 reference

20 August 2017

0 references

1 reference

1 reference

Jean Ferrières

1

1 reference

20 August 2017

publication date

1 January 2009

1 reference

American journal of cardiovascular drugs

20 August 2017

published in

1 reference

20 August 2017

volume

9

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

109-115

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256582

20 August 2017

exact match

0 references

cites work

Lipoprotein cholesterol and atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Intertwining of thrombosis and inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Pharmacological basis of different targets for the treatment of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Surrogate markers for atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Measurement of subclinical atherosclerosis: beyond risk factor assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Is intravascular ultrasound the gold standard surrogate for clinically relevant atherosclerosis progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256582

21 January 2018

Identifiers

DOI

10.1007/BF03256582

1 reference

20 August 2017

1 reference